Create a free account or log in.
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly.
The company is focused on two projects. KL1333, a powerful NAD⁺ regulator, is in clinical development and has been granted orphan drug designation in Europe and the US. NV354, an energy replacement (succinate) therapy, will enter the clinic in 2022.
Worldwide
Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).
| Filing Information | Date & Language | Document Details | Actions |
|---|
No filings found matching your criteria
| Person (Position) | Type | Volume | Price | Date |
|---|---|---|---|---|
|
↓
David Bejker
(Other)
|
Sell | SEK 121,052.25 | SEK 0.45 | 07.02.25 |
|
◆
Catharina Janzon Johansson
(Other)
|
Other | SEK 60,000.00 | SEK 0.03 | 31.05.24 |
|
◆
David Laskow-Pooley
(Other)
|
Other | SEK 30,000.00 | SEK 0.03 | 28.05.24 |
|
↑
David Laskow-Pooley
(Other)
|
Buy | SEK 11,664.58 | SEK 0.21 | 13.07.23 |
|
↑
David Laskow-Pooley
(Other)
|
Buy | SEK 8,151.00 | SEK 0.21 | 13.07.23 |
|
↑
David Laskow-Pooley
(Other)
|
Buy | SEK 7,807.86 | SEK 0.21 | 13.07.23 |
|
↑
David Laskow-Pooley
(Other)
|
Buy | SEK 3,267.20 | SEK 0.21 | 13.07.23 |
|
↑
David Laskow-Pooley
(Other)
|
Buy | SEK 2,588.47 | SEK 0.21 | 13.07.23 |
|
↑
David Laskow-Pooley
(Other)
|
Buy | SEK 2,479.40 | SEK 0.22 | 13.07.23 |
|
↑
David Laskow-Pooley
(Other)
|
Buy | SEK 2,474.86 | SEK 0.21 | 13.07.23 |
IKM
Sector
Health Care
Country
Spain
ISIN
Founded
1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.
2CUREX
Sector
Health Care
Country
Sweden
ISIN
SE0010468124
Founded
2cureX AB is a Danish biotech company specializing in functional precision medicine. It develops diagnostic tools to personalize cancer treatment.
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABERA
Sector
Health Care
Country
Sweden
ISIN
SE0015245097
Founded
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
AB
Sector
Health Care
Country
France
ISIN
FR0010557264
Founded
2001
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …